Head and neck cancer in Hong Kong.

about

Head and neck cancer in Hong Kong.

Item

http://www.wikidata.org/entity/Q49960053

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Head and neck cancer in Hong Kong.

@en

Head and neck cancer in Hong Kong.

@nl

type

Item

label

Head and neck cancer in Hong Kong.

@en

Head and neck cancer in Hong Kong.

@nl

prefLabel

Head and neck cancer in Hong Kong.

@en

Head and neck cancer in Hong Kong.

@nl

P1476

Head and neck cancer in Hong Kong

@en

P2093

Anne W M Lee

http://www.w3.org/2001/XMLSchema#string

Edwin C Y Wong

http://www.w3.org/2001/XMLSchema#string

Jimmy Y W Chan

http://www.w3.org/2001/XMLSchema#string

Victor H F Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical recommendations for defining platinum unsuitable head and neck cancer patient populations on chemoradiotherapy: A literature review

Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma

Human papillomavirus and survival of patients with oropharyngeal cancer.

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or ..

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group.

What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis.

A phase II study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma.

Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study.

P304

13-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JJCO/HYX151

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wai Tong Ng

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29145620

http://www.w3.org/2001/XMLSchema#string